Under the expert care of Aloni Le, DNP, ARNP, FNP-C , we bring together years of clinical experience, advanced medical knowledge, and a true passion for patient-centered care
Among these, liraglutide in the LEADER study, semaglutide in the SUSTAIN-6, albiglutide in the Harmony Outcomes, dulaglutide in the REWIND, and efpeglenatide in the AMPLITUDE-O exhibited significant beneficial effects on 3-point major adverse cardiac events (3P-MACE: death from CV disease, non-fatal myocardial infarction, and non-fatal stroke), the primary end point of each study, compared to the placebo group, respectively
Preparation and storage Research-only handling information
Better Absorption Since the nutrients go straight into your bloodstream, your body gets the full benefitno loss through digestion
The peptide's therapeutic potential extends beyond mere neuroprotection to actual neural repair and regeneration
Stefan, N., Haring, H